Cancer News
New drug helps against hormone-resistant breast cancer
A trial showed that an investigational medication for breast cancer improved progression free survival in patients with Hormone-Resistant positive (HR+) tumors.
Follow-up scans proved beneficial for lung cancer patients
New research illustrates the high value of PET/CT scans for lung cancer patients, based on how much they can help clinical assessment and management of patients.
Important FDA drug approval for multiple myeloma patients
Revlimid, already approved as a treatment for previously treated patients of multiple myeloma, will be available for newly diagnosed patients as well.
Common menopause treatment increases ovarian cancer risk
Women who take hormone replacement therapy for menopause (even for a few years) may face an increased risk of ovarian cancer, according to a detailed analysis.
New thyroid cancer drug gets early approval
The FDA approved lenvatinib for the treatment of thyroid cancer, two months ahead of its initial approval date in April.
Lenvatinib: beneficial for thyroid cancer patients or not?
Lenvatinib improved progression-free survival in thyroid cancer patients but median overall survival was not reached and serious adverse events were recorded.
Earlier, intense radiation after prostatectomy benefits patients
Prostate cancer patients with detectable prostate specific antigen (PSA) after radical prostatectomy should receive earlier, more aggressive radiation treatment.
Prostate cancer drug proven beneficial if taken before chemotherapy
Prostate cancer drug abiraterone was found to significantly extend the lives of men with advanced prostate cancer if given before chemotherapy, in a trial.
Another reason to quit smoking after surviving colorectal cancer
Smoking after surviving colorectal cancer was found to double the risk of cancer-caused mortality compared to non-smoking survivors.
Novel treatment approved for metastatic breast cancer
The FDA approved Palbociclib for the treatment of postmenopausal women with advanced breast cancer that is hormone receptor-positive.
New tool helps women with breast cancer avoid surgery
Ultrasound was found to be an effective tool in determining which breast cancer patients really need to proceed with surgical removal of lymph nodes.
New approved treatment for melanoma
The US FDA has granted accelerated approval to nivolumab for the treatment of unresectable or metastatic melanoma.
Could a gene link lung cancer with Parkinson's disease?
A gene mutation, previously related with early-onset Parkinson's disease, was found to be associated with lung cancer.
Radiotherapy may be unnecessary for some breast cancer patients
Some older women with breast cancer may avoid radiotherapy, without harming their chances of survival, a study has shown.
Smoking and prostate cancer: a dangerous combination
Smokers with prostate cancer face increased risks of experiencing side effects from treatment and of developing future cancer recurrences.
A more reliable diagnostic tool in prostate cancer
Targeted MRI/ultrasound has been found to be more effective than standard biopsy in detecting high-risk prostate cancer in a large scale study.
Genetics may be responsible for head and neck cancers
Head and neck cancers in young adults are more likely to be as a result of inherited factors, rather than lifestyle factors such as smoking or drinking alcohol.
Think twice before you choose hormonal contraceptives
Long term use of hormonal contraceptives has been associated with a possible increase in a young woman's risk of developing glioma, a rare brain tumor.
Genes to blame for drug resistance in testicular cancer
Researchers reveal new genetic mutations that could drive testicular cancer, and a gene which may contribute to resistance to drugs against the disease.
New effective treatment in metastatic breast cancer?
Increased overall survival in women with breast cancer who received Eribulin, a chemotherapeutic agent, as a first and second line chemotherapy regimen.
Metastatic colon cancer patients benefit from combination therapy
FOLFOXIRI combined with bevacizumab extended survival in patients with advanced colon cancer compared to the standard FOLFIRI chemotherapy with bevacizumab.
Ramucirumab extends survival for advanced colorectal cancer patients
Combining the targeted drug ramucirumab and FOLFIRI chemotherapy provides a survival advantage over standard treatment with FOLFIRI alone, a phase 3 study reports.
Could testosterone shrink advanced prostate tumors?
In a surprising paradox during a trial, testosterone, generally thought to be a feeder of prostate cancer, was found to suppress some advanced prostate cancers.
Combined therapy may help women with breast cancer live longer
Almost all women with HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug were cancer-free after 3 years.
Your cancer is not a just matter of “bad luck”
Scientists disapprove of a new study which supports the idea that bad luck is to blame for cancer, more than hereditary or external environmental factors.
Details of DNA damaged by smoking under research
Researchers have succeeded in amplifying genes altered by activities possibly causing lung cancer such as smoking, enabling deeper analysis of cancer causes.
Surgery: unnecessary for patients with rectal cancer?
Similar survival rates measured on rectal cancer patients regardless of whether they had immediate surgery or pursued a “watch and wait” surveillance approach.
Vitamin D may help fight colon cancer
High levels of vitamin D linked to an average 33% increase on survival rate in patients with metastatic colorectal cancer.
Sipuleucel-T in prostate cancer: More harm than good
Evaluating Sipuleucel-T, a prostate cancer drug, did not show proof of benefit in overall survival or patients’ health-related quality of life.
Triple-negative breast cancer: the answer is in the genes
A gene, identified to be overactive in triple-negative breast cancer, raises hopes for new targeted treatments in this aggressive difficult-to-treat cancer subtype.